Arctic Bioscience AS (OSL:ABS)

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
B2C	4.85M	4.95M	4.28M	3.49M			-
B2B	35.25M	38.53M	29.47M	30.78M			-
Pharmaceuticals	-	-	-	-			30.04M
Total	40.10M	43.48M	33.75M	34.27M			30.04M

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Norway	7.29M	6.89M	6.04M	4.96M			-
Americas	13.32M	5.47M	5.52M	7.62M			-
Europe	11.46M	18.55M	12.42M	8.50M			-
APAC	8.02M	12.57M	9.77M	13.19M			-
Total	40.10M	43.48M	33.75M	34.27M			-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error